Your browser doesn't support javascript.
loading
[Efficacy and safety of bendamustine-rituximab combination therapy for newly diagnosed indolent B-cell non-Hodgkin's lymphoma and elderly mantle cell lymphoma: a multi-center prospective phase II clinical trial in China].
Wang, H; He, Q; Liu, D; Deng, X Z; Ma, J; Xie, L N; Sun, Z L; Liu, C; Zhao, R R; Lu, K; Chu, X X; Gao, N; Wei, H C; Sun, Y H; Zhong, Y P; Xing, L J; Zhang, H Y; Zhang, H; Xu, W W; Li, Z J.
Affiliation
  • Wang H; Department of Hematology, Shandong Cancer Hospital and Institute, Shandong First Medical University and Shandong Academy of Medical Sciences, Jinan 250000, China.
  • He Q; Department of Hematology, Shandong Cancer Hospital and Institute, Shandong First Medical University and Shandong Academy of Medical Sciences, Jinan 250000, China.
  • Liu D; Department of Hematology, Shandong Cancer Hospital and Institute, Shandong First Medical University and Shandong Academy of Medical Sciences, Jinan 250000, China.
  • Deng XZ; Department of Hematology, Weihai Municipal Hospital, Weihai 264200, China.
  • Ma J; Department of Hematology, Shandong Cancer Hospital and Institute, Shandong First Medical University and Shandong Academy of Medical Sciences, Jinan 250000, China.
  • Xie LN; Department of Hematology, Shandong Cancer Hospital and Institute, Shandong First Medical University and Shandong Academy of Medical Sciences, Jinan 250000, China.
  • Sun ZL; Department of Hematology, Jining First People's Hospital, Jining 272000, China.
  • Liu C; Department of Hematology, Shandong Cancer Hospital and Institute, Shandong First Medical University and Shandong Academy of Medical Sciences, Jinan 250000, China.
  • Zhao RR; Department of Hematology, Shandong Cancer Hospital and Institute, Shandong First Medical University and Shandong Academy of Medical Sciences, Jinan 250000, China.
  • Lu K; Department of Hematology, Shandong Cancer Hospital and Institute, Shandong First Medical University and Shandong Academy of Medical Sciences, Jinan 250000, China.
  • Chu XX; Department of Hematology, The Affiliated Yantai Yuhuangding Hospital of Qingdao University, Yantai 264000, China.
  • Gao N; Department of Hematology, Binzhou Medical University Hospital, Binzhou 256600, China.
  • Wei HC; Department of Hematology, Shandong Cancer Hospital and Institute, Shandong First Medical University and Shandong Academy of Medical Sciences, Jinan 250000, China.
  • Sun YH; Department of Hematology, Weifang People's Hospital, Weifang 261000, China.
  • Zhong YP; Department of Hematology, Qingdao Municipal Hospital, Qingdao 266000, China.
  • Xing LJ; Department of Hematology, Shandong Cancer Hospital and Institute, Shandong First Medical University and Shandong Academy of Medical Sciences, Jinan 250000, China.
  • Zhang HY; Department of Hematology, Linyi People's Hospital, Linyi 276000, China.
  • Zhang H; Department of Hematology, Affiliated Hospital of Jining Medical University, Jining 272000, China.
  • Xu WW; Department of Hematology, The First Affiliated Hospital of Shandong First Medical University, Jinan 250000, China.
  • Li ZJ; Department of Hematology, Shandong Cancer Hospital and Institute, Shandong First Medical University and Shandong Academy of Medical Sciences, Jinan 250000, China.
Zhonghua Xue Ye Xue Za Zhi ; 44(7): 550-554, 2023 Jul 14.
Article in Zh | MEDLINE | ID: mdl-37749033
Subject(s)
Key words
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Lymphoma, Follicular / Lymphoma, Mantle-Cell / Leukopenia Type of study: Clinical_trials / Diagnostic_studies / Observational_studies Limits: Adult / Aged / Humans / Middle aged Country/Region as subject: Asia Language: Zh Journal: Zhonghua Xue Ye Xue Za Zhi Year: 2023 Document type: Article Affiliation country: Country of publication:
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Lymphoma, Follicular / Lymphoma, Mantle-Cell / Leukopenia Type of study: Clinical_trials / Diagnostic_studies / Observational_studies Limits: Adult / Aged / Humans / Middle aged Country/Region as subject: Asia Language: Zh Journal: Zhonghua Xue Ye Xue Za Zhi Year: 2023 Document type: Article Affiliation country: Country of publication: